Healthy Living Arizona
SEE OTHER BRANDS

Following health and wellness news from Arizona

Healthy Living Arizona: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Healthy Living Arizona.

Press releases published on July 15, 2025

Phyllis Gasparro Launches Hypnotherapy Practice in Tucson, Supporting Stress Relief, Emotional Healing & Growth

Phyllis Gasparro Launches Hypnotherapy Practice in Tucson, Supporting Stress Relief, Emotional Healing & Growth

Empowering clients with heart-centered hypnotherapy to create lasting inner change TUCSON, AZ, UNITED STATES, July 15, 2025 /⁨EINPresswire.com⁩/ -- Certified Hypnotherapist Phyllis Gasparro, CMS-CHt, FIBH, is proud to announce the launch of her …

ORANGE BIOMED TO SHOWCASE LAB-QUALITY PORTABLE DIABETES TESTING TECHNOLOGY TO 2,500+ SPECIALISTS AT ADCES25

ORANGE BIOMED TO SHOWCASE LAB-QUALITY PORTABLE DIABETES TESTING TECHNOLOGY TO 2,500+ SPECIALISTS AT ADCES25

Preview of new HbA1c tech that requires minimal blood sample, reduces lab delays, …

Mesa Clinic Announces New Data-Driven, Personalized Weight Management Program

Mesa Clinic Announces New Data-Driven, Personalized Weight Management Program

MESA, AZ, UNITED STATES, July 15, 2025 /⁨EINPresswire.com⁩/ -- BioBuddy Wellness and Weight Loss has launched a medical weight management initiative focused on individualized care and sustainable lifestyle modifications. The Mesa-based clinic aims to …

Biotricity to Host Fiscal 2025 Fourth Quarter Financial Results and Business Update Call on July 18th

Biotricity to Host Fiscal 2025 Fourth Quarter Financial Results and Business Update Call on July 18th

Company to announce improvements in Margins, Operational Efficiency, and a shift to positive Adjusted EBITDA REDWOOD CITY, Calif., July 15, 2025 (GLOBE NEWSWIRE) -- Biotricity Inc. (OTCQB:BTCY), an innovative Technology-as-a-Service (TaaS) company …

Aptose Receives Second Advance under the Loan Agreement with Hanmi Pharmaceutical to Continue Development of Tuspetinib in Triplet Therapy for AML

Aptose Receives Second Advance under the Loan Agreement with Hanmi Pharmaceutical to Continue Development of Tuspetinib in Triplet Therapy for AML

SAN DIEGO and TORONTO, July 15, 2025 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. ("Aptose" or the "Company") (TSX: APS; OTC: APTOF), a clinical-stage precision oncology company developing a tuspetinib (TUS) based triple drug frontline therapy to treat …

Gain Therapeutics Announces Proposed Public Offering

Gain Therapeutics Announces Proposed Public Offering

BETHESDA, Md., July 15, 2025 (GLOBE NEWSWIRE) -- Gain Therapeutics, Inc. (Nasdaq: GANX) (“Gain”, or the “Company”), a clinical-stage biotechnology company leading the discovery and development of the next generation of allosteric small molecule therapies, …

ADR Ratio Change

ADR Ratio Change

July 15, 2025 Biodexa Pharmaceuticals PLC (“Biodexa” or the “Company”) ADR Ratio Change Biodexa Pharmaceuticals PLC (Nasdaq: BDRX), an acquisition-focused clinical stage biopharmaceutical company developing a pipeline of innovative products for the …

Globus Medical Introduces DuraPro™ with Navigation, a Next-Generation, Oscillating System Designed to Safeguard Delicate Tissue

Globus Medical Introduces DuraPro™ with Navigation, a Next-Generation, Oscillating System Designed to Safeguard Delicate Tissue

AUDUBON, Pa., July 15, 2025 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, today announced the expanded Excelsius™ navigation capabilities of its next-generation oscillating system, DuraPro™, as the …

Ikena Oncology Announces Stockholder Approval of Merger with Inmagene Biopharmaceuticals

Ikena Oncology Announces Stockholder Approval of Merger with Inmagene Biopharmaceuticals

Combined Company to Trade on Nasdaq Under Ticker “IMA” Ikena Announces 1-for-12 Reverse Stock Split of Ikena Common Stock BOSTON and SAN DIEGO, July 15, 2025 (GLOBE NEWSWIRE) -- Ikena Oncology, Inc. (Nasdaq: IKNA) (“Ikena”) today announced the results of …

Adaptive Biotechnologies to Report Second Quarter 2025 Financial Results on August 5, 2025

Adaptive Biotechnologies to Report Second Quarter 2025 Financial Results on August 5, 2025

SEATTLE, July 15, 2025 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical products to diagnose and treat disease, …

Autolus Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Autolus Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

LONDON …

Sanara MedTech to Report Second Quarter 2025 Financial Results on August 13, 2025

Sanara MedTech to Report Second Quarter 2025 Financial Results on August 13, 2025

FORT WORTH, TX, July 15, 2025 (GLOBE NEWSWIRE) -- Sanara MedTech Inc. (“Sanara,” or the “Company”) (Nasdaq: SMTI), a medical technology company focused on developing and commercializing transformative technologies to improve clinical outcomes and reduce …

Exagen Inc. to Announce Second Quarter 2025 Financial Results on July 29, 2025

Exagen Inc. to Announce Second Quarter 2025 Financial Results on July 29, 2025

CARLSBAD, Calif., July 15, 2025 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of innovative autoimmune testing, will release financial results for the quarter ended June 30, 2025, before the market opens on Tuesday, July 29, 2025. John …

Kestra Medical Technologies Reports Fourth Quarter and Fiscal Year 2025 Financial Results

Kestra Medical Technologies Reports Fourth Quarter and Fiscal Year 2025 Financial Results

KIRKLAND, Wash., July 15, 2025 (GLOBE NEWSWIRE) -- Kestra Medical Technologies, Ltd. (Nasdaq: KMTS), a wearable medical device and digital healthcare company, today reported financial results for the fourth quarter and fiscal year ended April 30, 2025. …

Biocon Biologics Expands Diabetes Portfolio with FDA Approval of Kirsty™, the First and Only Interchangeable Rapid-Acting Insulin Aspart in the United States

Biocon Biologics Expands Diabetes Portfolio with FDA Approval of Kirsty™, the First and Only Interchangeable Rapid-Acting Insulin Aspart in the United States

BRIDGEWATER, N.J., United States and BENGALURU, Karnataka, India, July 15, 2025 (GLOBE NEWSWIRE) -- Biocon Biologics Ltd (BBL), a fully integrated global biosimilars company and subsidiary of Biocon Ltd. (BSE code: 532523, NSE: BIOCON), today announced …

XLA Health Launches Modern Outsourcing Platform to Help Medical Practices Slash Administrative Overload

XLA Health Launches Modern Outsourcing Platform to Help Medical Practices Slash Administrative Overload

New York, NY, July 15, 2025 (GLOBE NEWSWIRE) -- XLA Health (www.xlahealth.com) officially rebrands its HIPAA-compliant outsourcing platform designed to relieve private‐practice physicians of the everyday administrative grind. By pairing college-educated, …

Tivity Health Appoints Natasha Deckmann as CEO

Tivity Health Appoints Natasha Deckmann as CEO

NASHVILLE, Tenn., July 15, 2025 (GLOBE NEWSWIRE) -- Tivity Health, a leading provider of healthy lifestyle solutions, including SilverSneakers®, Prime® Fitness, and WholeHealth Living®, announced today that Natasha Deckmann, M.D., has been named Chief …

BriaCell Therapeutics Announces Pricing of $15 million Public Offering

BriaCell Therapeutics Announces Pricing of $15 million Public Offering

PHILADELPHIA and VANCOUVER, British Columbia, July 15, 2025 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW, BCTXZ) (TSX: BCT) (“BriaCell” or the “Company”), a clinical-stage biotechnology company that develops novel immunotherapies to …

Dr. Zachary Solomon Launches National Medical Tech Grant to Drive Healthcare Innovation Among U.S. Undergraduates

Dr. Zachary Solomon Launches National Medical Tech Grant to Drive Healthcare Innovation Among U.S. Undergraduates

PHILADELPHIA, July 15, 2025 (GLOBE NEWSWIRE) -- Renowned cardiothoracic surgeon Dr. Zachary Solomon has officially announced the launch of the Dr. Zachary Solomon Medical Tech Grant, a prestigious academic initiative aimed at cultivating future leaders in …

As Mobile Scanners Multiply Across Industries, Ergodyne Delivers the Fix for Loss, Damage and Downtime

As Mobile Scanners Multiply Across Industries, Ergodyne Delivers the Fix for Loss, Damage and Downtime

St. Paul, MN, July 15, 2025 (GLOBE NEWSWIRE) -- The surge in mobile device usage across warehousing, retail, logistics and beyond has made scanners indispensable. But it’s also introduced costly problems. From misplaced gear to costly breaks, businesses …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms of Service